Using AI to Track GA Treatment Response

Ursula M. Schmidt-Erfurth, MD

Show Description +

Dr. Schmidt-Erfurth explores the use of OCT-based AI to identify disease activity and therapeutic response in patients with geographic atrophy being treated with pegcetacoplan (Syfovre, Apellis).

Posted: 8/06/2024

Keywords:

retina-meeting-recap

•

Geographic Atrophy (GA)

•

Artificial Intelligence

•

Optical coherence tomography (OCT)

•

Pegcetacoplan

•

Syfovre

•

Apellis

Up Next

Name: Using AI to Track GA Treatment Response
Uploaded: 2024-08-06T14:43:30+00:00
Description: Dr. Schmidt-Erfurth explores the use of OCT-based AI to identify disease activity and therapeutic response in patients with geographic atrophy being treated with pegcetacoplan (Syfovre, Apellis).

More on Faricimab for DME: Efficacy and Safety

Chirag Jhaveri, MD

96-Week Safety Data Revealed for 8 mg Aflibercept

Christina Y. Weng, MD, MBA

Exploring DME Outcomes Based on Baseline Vision

Diana V. Do, MD

The PDS: Technical Changes and Clinical Experiences

Dante J. Pieramici, MD

Pegcetacoplan in the Trials and the Real-World

David A. Eichenbaum, MD

An Update on AVD-104 for the Treatment of GA

Rishi P. Singh, MD

Gene Therapy for Wet AMD Shows Promise

Charles C. Wykoff, MD, PhD, FASRS, FACS

Using Retinal Imaging to Identify Alzheimer Biomarkers

Sruthi Arepalli, MD

The Effect of Vitrectomy on AMD Progression

Chase Ludwig, MD

Back to All Videos

Using AI to Track GA Treatment Response

Ursula M. Schmidt-Erfurth, MD

Dr. Schmidt-Erfurth explores the use of OCT-based AI to identify disease activity and therapeutic response in patients with geographic atrophy being treated with pegcetacoplan (Syfovre, Apellis).

Posted: 8/06/2024

Keywords:

retina-meeting-recap

•

Geographic Atrophy (GA)

•

Artificial Intelligence

•

Optical coherence tomography (OCT)

•

Pegcetacoplan

•

Syfovre

•

Apellis

Please log in to leave a comment.

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

Using AI to Track GA Treatment Response

Up Next

Using AI to Track GA Treatment Response

More From ASRS: 2024 Coverage